Literature DB >> 29938567

Global profiling of hnRNP A2/B1-RNA binding on chromatin highlights LncRNA interactions.

Eric D Nguyen1,2,3, Maggie M Balas1,2,4, April M Griffin2, Justin T Roberts1,2, Aaron M Johnson1,2,4.   

Abstract

Long noncoding RNAs (lncRNAs) often carry out their functions through associations with adaptor proteins. We recently identified heterogeneous ribonucleoprotein (hnRNP) A2/B1 as an adaptor of the human HOTAIR lncRNA. hnRNP A2 and B1 are splice isoforms of the same gene. The spliced version of HOTAIR preferentially associates with the B1 isoform, which we hypothesize contributes to RNA-RNA matching between HOTAIR and transcripts of target genes in breast cancer. Here we used enhanced cross-linking immunoprecipitation (eCLIP) to map the direct interactions between A2/B1 and RNA in breast cancer cells. Despite differing by only twelve amino acids, the A2 and B1 splice isoforms associate preferentially with distinct populations of RNA in vivo. Through cellular fractionation experiments we characterize the pattern of RNA association in chromatin, nucleoplasm, and cytoplasm. We find that a majority of interactions occur on chromatin, even those that do not contribute to co-transcriptional splicing. A2/B1 binding site locations on multiple RNAs hint at a contribution to the regulation and function of lncRNAs. Surprisingly, the strongest A2/B1 binding site occurs in a retained intron of HOTAIR, which interrupts an RNA-RNA interaction hotspot. In vitro eCLIP experiments highlight additional exonic B1 binding sites in HOTAIR which also surround the RNA-RNA interaction hotspot. Interestingly, a version of HOTAIR with the intron retained is still capable of making RNA-RNA interactions in vitro through the hotspot region. Our data further characterize the multiple functions of a repurposed splicing factor with isoform-biased interactions, and highlight that the majority of these functions occur on chromatin-associated RNA.

Entities:  

Keywords:  HOTAIR; RNA-RNA interactions; Xist; chromatin; hnRNP A2/B1; long noncoding RNA

Mesh:

Substances:

Year:  2018        PMID: 29938567      PMCID: PMC6161681          DOI: 10.1080/15476286.2018.1474072

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  53 in total

1.  Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells.

Authors:  J Wysocka; P T Reilly; W Herr
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Characterization of the mouse hnRNP A2/B1/B0 gene and identification of processed pseudogenes.

Authors:  Jodie T Hatfield; Joseph A Rothnagel; Ross Smith
Journal:  Gene       Date:  2002-07-24       Impact factor: 3.688

3.  Differential subnuclear localisation of hnRNPs A/B is dependent on transcription and cell cycle stage.

Authors:  Lexie R Friend; Siew Ping Han; Joseph A Rothnagel; Ross Smith
Journal:  Biochim Biophys Acta       Date:  2008-06-06

Review 4.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

5.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

6.  Telomere- and telomerase-interacting protein that unfolds telomere G-quadruplex and promotes telomere extension in mammalian cells.

Authors:  Feng Wang; Ming-liang Tang; Zhi-xiong Zeng; Ren-yi Wu; Yong Xue; Yu-hua Hao; Dai-wen Pang; Yong Zhao; Zheng Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

7.  Systematic discovery of structural elements governing stability of mammalian messenger RNAs.

Authors:  Hani Goodarzi; Hamed S Najafabadi; Panos Oikonomou; Todd M Greco; Lisa Fish; Reza Salavati; Ileana M Cristea; Saeed Tavazoie
Journal:  Nature       Date:  2012-04-08       Impact factor: 49.962

8.  Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP).

Authors:  Eric L Van Nostrand; Gabriel A Pratt; Alexander A Shishkin; Chelsea Gelboin-Burkhart; Mark Y Fang; Balaji Sundararaman; Steven M Blue; Thai B Nguyen; Christine Surka; Keri Elkins; Rebecca Stanton; Frank Rigo; Mitchell Guttman; Gene W Yeo
Journal:  Nat Methods       Date:  2016-03-28       Impact factor: 28.547

Review 9.  Advances and challenges in the detection of transcriptome-wide protein-RNA interactions.

Authors:  Emily C Wheeler; Eric L Van Nostrand; Gene W Yeo
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-08-29       Impact factor: 9.957

10.  Fractionation iCLIP detects persistent SR protein binding to conserved, retained introns in chromatin, nucleoplasm and cytoplasm.

Authors:  Mattia Brugiolo; Valentina Botti; Na Liu; Michaela Müller-McNicoll; Karla M Neugebauer
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

View more
  10 in total

1.  RNA-binding proteins direct myogenic cell fate decisions.

Authors:  Joshua R Wheeler; Oscar N Whitney; Thomas O Vogler; Eric D Nguyen; Bradley Pawlikowski; Evan Lester; Alicia Cutler; Tiffany Elston; Nicole Dalla Betta; Kevin R Parker; Kathryn E Yost; Hannes Vogel; Thomas A Rando; Howard Y Chang; Aaron M Johnson; Roy Parker; Bradley B Olwin
Journal:  Elife       Date:  2022-06-13       Impact factor: 8.713

Review 2.  RNA matchmaking in chromatin regulation.

Authors:  Stephen K Wu; Justin T Roberts; Maggie M Balas; Aaron M Johnson
Journal:  Biochem Soc Trans       Date:  2020-12-18       Impact factor: 5.407

3.  HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.

Authors:  Carolyn M Klinge; Kellianne M Piell; Christine Schaner Tooley; Eric C Rouchka
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

4.  Systematic Investigation of mRNA N 6-Methyladenosine Machinery in Primary Prostate Cancer.

Authors:  Mei Jiang; Yali Lu; Dongxia Duan; Hongxiang Wang; Gaoya Man; Ching Kang; Kesaier Abulimiti; Yao Li
Journal:  Dis Markers       Date:  2020-11-12       Impact factor: 3.434

5.  Antagonism between splicing and microprocessor complex dictates the serum-induced processing of lnc-MIRHG for efficient cell cycle reentry.

Authors:  Qinyu Sun; Qinyu Hao; Yo-Chuen Lin; You Jin Song; Sushant Bangru; Waqar Arif; Vidisha Tripathi; Yang Zhang; Jung-Hyun Cho; Susan M Freier; Lisa M Jenkins; Jian Ma; Je-Hyun Yoon; Auinash Kalsotra; Ashish Lal; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  RNA       Date:  2020-07-16       Impact factor: 4.942

6.  Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma.

Authors:  Tingting Jia; Fengze Wang; Bo Qiao; Yipeng Ren; Lejun Xing; Haizhong Zhang; Hongbo Li
Journal:  Front Mol Biosci       Date:  2021-03-26

7.  Establishing RNA-RNA interactions remodels lncRNA structure and promotes PRC2 activity.

Authors:  Maggie M Balas; Erik W Hartwick; Chloe Barrington; Justin T Roberts; Stephen K Wu; Ryan Bettcher; April M Griffin; Jeffrey S Kieft; Aaron M Johnson
Journal:  Sci Adv       Date:  2021-04-14       Impact factor: 14.136

Review 8.  Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.

Authors:  Ya Lu; Xinyue Wang; Quan Gu; Juan Wang; Ying Sui; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Discov       Date:  2022-07-25

9.  Knockdown of LINC00662 represses AK4 and attenuates radioresistance of oral squamous cell carcinoma.

Authors:  Yangzong Chen; Chunchun Bao; Xiuxing Zhang; Xinshi Lin; Yimou Fu
Journal:  Cancer Cell Int       Date:  2020-06-16       Impact factor: 5.722

10.  HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.

Authors:  Belinda J Petri; Kellianne M Piell; Gordon C South Whitt; Ali E Wilt; Claire C Poulton; Norman L Lehman; Brian F Clem; Matthew A Nystoriak; Marcin Wysoczynski; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2021-07-14       Impact factor: 9.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.